The Role of Antioxidants and Anti-Inflammatory Agents in Cardiometabolic Disease
Abstract
Cardiovascular diseases remain a major cause of morbidity and mortality worldwide. Cardiovascular diseases associated with metabolic disorders are collectively referred to as Cardiometabolic Diseases (CMDs). Oxidative stress and inflammation are key contributors to the development and progression of CMDs. Antioxidants and anti-inflammatory agents have garnered significant attention as potential therapeutic strategies for preventing and managing cardiovascular disorders. To better understand the complex interactions between oxidative stress, inflammation, and cardiovascular health, this review paper will focus on the mechanisms of action and potential advantages of antioxidants and anti-inflammatory drugs in reducing the risk factors associated with CVDs and enhancing cardiovascular health in general.
Keywords
Full Text:
PDFReferences
Lindstrom M, Decleene N, Dorsey H, et al. Summary of Global Burden of Disease Study Methods. J Am Coll Cardiol. 2022;80(25):2372-2425. doi:10.1016/j.jacc.2022.11.001
Banez MJ, Geluz MI, Chandra A, et al. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Nutr Res. 2020;78:11-26. doi:10.1016/j.nutres.2020.03.002
Taleb A, Ahmad KA, Ihsan AU, et al. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomed Pharmacother. 2018;102:689-698. doi:10.1016/j.biopha.2018.03.140
Prasad AS. Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health. Front Nutr. 2014;1. doi:10.3389/fnut.2014.00014
Adameov A, Ferenczyov K, Bartekov M, Lazou A, Dhalla NS. Free Radical Biology and Medicine Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases O ˇ lga Pech a. 2021;169:446-477. doi:10.1016/j.freeradbiomed.2021.03.045
Aune D, Feng T, Schlesinger S, Janszky I. PT SC. 2018;(2017):#pagerange#. doi:10.1016/j.jdiacomp.2018.02.004
Vona R, Gambardella L, Cittadini C, Straface E. Review Article Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases. 2019;2019.
Varga Z V, Kupai K, Gáspár R, et al. Journal of Molecular and Cellular Cardiology MicroRNA-25-dependent up-regulation of NADPH oxidase 4 ( NOX4 ) mediates hypercholesterolemia-induced oxidative / nitrative stress and subsequent dysfunction in the heart. 2013;62:111-121. doi:10.1016/j.yjmcc.2013.05.009
Bl M. Adipose tissue inflammation : a cause or consequence of obesity-related insulin resistance ? Published online 2016:1603-1614. doi:10.1042/CS20160005
Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Published online 2021:423-434. doi:10.1093/cvr/cvaa217
Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Published online 2017:389-398. doi:10.1093/cvr/cvx012
Lacy P, Murray RZ, Moraes-vieira PM. The Macrophage Switch in Obesity Development. 2016;6(January):1-11. doi:10.3389/fimmu.2015.00637
Lancaster GI, Langley KG, Berglund NA, et al. Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism Article Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by. Cell Metab. 2018;27(5):1096-1110.e5. doi:10.1016/j.cmet.2018.03.014
Packer M, Kitzman DW. Obesity-Related Heart Failure With a Preserved Ejection Fraction. JACC Hear Fail. 2018;6(8):633-639. doi:10.1016/j.jchf.2018.01.009
Schinzari F, Tesauro M, Veneziani A, Mores N, Daniele N Di, Cardillo C. Favorable Vascular Actions of Angiotensin-(1–7) in Human Obesity. Published online 2017:185-191. doi:10.1161/HYPERTENSIONAHA.117.10280
Tikellis C, Thomas MC, Harcourt BE, et al. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Published online 2023:323-330. doi:10.1152/ajpendo.00024.2008.
Florian A. Wenzl, Samuele Ambrosini, Shafeeq A. Mohammed SK, Thomas F. Lüscher SC and FP. Inflammation in Metabolic Cardiomyopathy. Published online 2021. doi:doi: 10.3389/fcvm.2021.742178
DOI: https://doi.org/10.21776/ub/hsj.2024.005.01.3
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Teguh Aryanugraha, Djanggan Sargowo
This work is licensed under a Creative Commons Attribution 4.0 International License.